Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P950037/S289

BIOexpress

Biotronik, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP950037/S289

What did the FDA approve?

The FDA record shows an approval decision dated 2026-10-16 for BIOexpress, listed as a dedicated interrogation-only device used for status checks of BIOTRONIK implantable pulse generators (IPGs, CRT-Ps), implantable cardioverter defibrillators (ICDs, CRT-Ds) and implantable cardiac monitors (ICMs). The supplement is identified as P950037/S289, a normal 180-day track filing whose stated reason is a change to design, components, specifications or material. The record does not specify which component, specification or material changed.

P950037/S289 is a supplement to the existing P950037 approval rather than a new approval of the whole system, and the record gives no manufacturing-notice detail. BIOexpress is described by category as an implantable pacemaker pulse-generator device under product code DXY in the Cardiovascular specialty. The reported interrogation-only purpose is the statement's own description, not independent evidence of safety or clinical effectiveness, and the record supplies no test data or clinical outcomes.

FDA approval order statement

BIOexpress, a dedicated interrogation-only device for status checks of BIOTRONIK implantable pulse generators (IPGs, CRT-Ps), implantable cardioverter defibrillators (ICDs, CRT-Ds) and implantable cardiac monitors (ICMs)
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P950037/S289
Regulatory pathway
PMA supplement
Product code
DXY
Decision code
APPR
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: implantable pacemaker Pulse-generator.

Product code
DXY
FDA device class
3

For the original device and its historical approval scope, see PMA P950037. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P950037 · Original PMA

    DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS

  2. P950037/S289 received

    Application receipt date recorded by FDA.

  3. P950037/S291 · Related supplement

    PSW 2601.U, NEO 2601.U, Amvia Sky HF-T QP, Amvia Sky HF-T, Amvia Edge HF-T QP, Amvia Sky DR-T, Amvia Sky SR-T, Amvia Edg

  4. P950037/S279 · Related supplement

    Edora 8 DR-T 407145, Evity 8 DR-T 407146, Enitra 8 DR-T 407147, Enticos 8 DR-T 407148, Evity 6 DR-T 407149, Enitra 6 DR-

  5. P950037/S296 · Related supplement

    Edora 8 DR-T 407145; Evity 8 DR-T 407146; Enitra 8 DR-T 407147; Enticos 8 DR-T 407148; Evity 6 DR-T 407149; Enitra 6 DR-

  6. P950037/S298 · Related supplement

    Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Evity 6 DR-T, Enitra 6 DR-T, Edora 8 DR, Enitra 6 DR, Enticos 4 DR, Enticos

  7. P950037/S289 · FDA decision

    Normal 180 Day Track

  8. P950037/S299 · Related supplement

    Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Enticos 8 DR-T, Evity 6 DR-T, Enitra 6 DR-T, Edora 8 DR, Enitra 6 DR, Edora 8

  9. P950037/S300 · Related supplement

    Amvia Sky DR-T, Amvia Sky SR-T; Amvia Edge DR-T, Amvia Edge SR-T; Solvia Rise DR-T, Solvia Rise SR-T; Amvia Sky HF-T QP,

Timeline entries are records held by MedtechLedger for P950037. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P950037

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records